| Effect of somatostatin on hyperamylasemia following endoscopic pancreatography. | |
| | |
MedLine Citation:
|
PMID: 2425529 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Prophylactic somatostatin (Stillamin, Serono) was given i.v. to 26 patients for 24 hours (250 micrograms/h) in order to reduce the incidence and severity of hyperamylasemia and pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP). Patients who during the preceding year had been subjected to ERCP served as historical controls. The incidence of hyperamylasemia following ERCP was 58% and 57% in somatostatin-treated patients and controls, respectively. There was no significant difference between the serum amylase levels in the controls and in patients given prophylactic somatostatin. No patient developed clinically overt pancreatitis. It is concluded that prophylactic somatostatin does not reduce the incidence or severity of hyperamylasemia following ERCP. |
| | |
Authors:
|
G Tydén; B Nyberg; T Sonnenfeld; L Thulin |
Related Documents
:
|
7658819 - Early antibiotic treatment in acute necrotising pancreatitis. 314279 - Possible hazard of timed-release aspirin in a patient with pancreatic insufficiency. 6206989 - Diagnostic and therapeutic applications of bentiromide screening test for exocrine panc... 3940259 - Hemodynamic data pattern in patients with acute pancreatitis. 6948539 - The lundh test: a review of its clinical use in the diagnosis of pancreatic disease. 17210309 - Evaluation of platybasia in patients with idiopathic trigeminal neuralgia. 566049 - Subarachnoid corticosteroid injection following inadequate response to epidural steroid... 16282749 - Activation markers in behçet's disease. 20448239 - Persistent symptomatic intra-abdominal collection after catheter removal for pd-related... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Acta chirurgica Scandinavica. Supplementum Volume: 530 ISSN: 0301-1860 ISO Abbreviation: Acta Chir Scand Suppl Publication Date: 1986 |
Date Detail:
|
Created Date: 1986-07-25 Completed Date: 1986-07-25 Revised Date: 2007-12-06 |
Medline Journal Info:
|
Nlm Unique ID: 0370305 Medline TA: Acta Chir Scand Suppl Country: SWEDEN |
Other Details:
|
Languages: eng Pagination: 43-5 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amylases
/
blood* Cholangiopancreatography, Endoscopic Retrograde* / adverse effects Evaluation Studies as Topic Humans Pancreatitis / etiology, prevention & control Somatostatin / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
51110-01-1/Somatostatin; EC 3.2.1.-/Amylases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gastric cancer. Factors influencing longterm survival and postoperative mortality.
Next Document: The effect of palliative biliodigestive operations for unresectable pancreatic cancer.